TREPROSTINIL TEVA 5 MGML

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

TREPROSTINIL AS SODIUM

Mevcut itibaren:

ABIC MARKETING LTD, ISRAEL

ATC kodu:

B01AC21

Farmasötik formu:

SOLUTION FOR INFUSION

Kompozisyon:

TREPROSTINIL AS SODIUM 5 MG/ML

Uygulama yolu:

S.C, I.V

Reçete türü:

Not required

Tarafından üretildi:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Terapötik alanı:

TREPROSTINIL

Terapötik endikasyonlar:

Treprostinil Teva is indicated for the treatment of:- Primary pulmonary arterial hypertension - Pulmonary arterial hypertension associated with connective tissue disorders.- Pulmonary hypertension associated with congenital systemic to pulmonary shunts.

Yetkilendirme tarihi:

2020-11-29